{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T20:25:33Z","timestamp":1791059133942,"version":"4.1.0"},"reference-count":232,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,7,9]],"date-time":"2024-07-09T00:00:00Z","timestamp":1720483200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cardiovascular Pathology"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1016\/j.carpath.2024.107673","type":"journal-article","created":{"date-parts":[[2024,7,10]],"date-time":"2024-07-10T18:21:52Z","timestamp":1720635712000},"page":"107673","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"special_numbering":"C","title":["Current concepts in the epigenetic regulation of cardiac fibrosis"],"prefix":"10.1016","volume":"73","author":[{"given":"Ali","family":"Fatehi Hassanabad","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna N.","family":"Zarzycki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vaibhav B.","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0658-9381","authenticated-orcid":false,"given":"Paul W.\u202fM.","family":"Fedak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.carpath.2024.107673_bib0001","doi-asserted-by":"crossref","first-page":"238","DOI":"10.3389\/fphys.2017.00238","article-title":"Current understanding of the pathophysiology of myocardial fibrosis and its quantitative assessment in heart failure","volume":"8","author":"Liu","year":"2017","journal-title":"Front Physiol"},{"issue":"4","key":"10.1016\/j.carpath.2024.107673_bib0002","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1007\/s00018-013-1349-6","article-title":"The pathogenesis of cardiac fibrosis","volume":"71","author":"Kong","year":"2014","journal-title":"Cell Mol Life Sci"},{"issue":"15","key":"10.1016\/j.carpath.2024.107673_bib0003","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1016\/j.jacc.2018.02.021","article-title":"Myocardial interstitial fibrosis in heart failure: biological and translational perspectives","volume":"71","author":"Gonz\u00e1lez","year":"2018","journal-title":"J Am Coll Cardiol"},{"issue":"23","key":"10.1016\/j.carpath.2024.107673_bib0004","doi-asserted-by":"crossref","first-page":"1832","DOI":"10.1136\/heartjnl-2019-315560","article-title":"Myocardial fibrosis: why image, how to image and clinical implications","volume":"105","author":"Bing","year":"2019","journal-title":"Heart"},{"key":"10.1016\/j.carpath.2024.107673_bib0005","doi-asserted-by":"crossref","first-page":"777","DOI":"10.3389\/fphys.2017.00777","article-title":"The processes and mechanisms of cardiac and pulmonary fibrosis","volume":"8","author":"Murtha","year":"2017","journal-title":"Front Physiol"},{"issue":"1","key":"10.1016\/j.carpath.2024.107673_bib0006","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1038\/nrcardio.2012.158","article-title":"Myofibroblast-mediated mechanisms of pathological remodelling of the heart","volume":"10","author":"Weber","year":"2013","journal-title":"Nat Rev Cardiol"},{"issue":"2","key":"10.1016\/j.carpath.2024.107673_bib0007","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.pharmthera.2009.05.002","article-title":"Cardiac fibroblasts: at the heart of myocardial remodeling","volume":"123","author":"Porter","year":"2009","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.carpath.2024.107673_bib0008","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.mam.2018.07.001","article-title":"Cardiac fibrosis: cell biological mechanisms, molecular pathways and therapeutic opportunities","volume":"65","author":"Frangogiannis","year":"2019","journal-title":"Mol Aspects Med"},{"key":"10.1016\/j.carpath.2024.107673_bib0009","doi-asserted-by":"crossref","DOI":"10.1016\/j.carpath.2024.107635","article-title":"Cellular and molecular mechanisms driving cardiac tissue fibrosis: on the precipice of personalized and precision medicine","volume":"71","author":"Fatehi Hassanabad","year":"2024","journal-title":"Cardiovasc Pathol"},{"key":"10.1016\/j.carpath.2024.107673_bib0010","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.yjmcc.2016.02.011","article-title":"Epigenetic regulation of cardiac fibrosis","volume":"92","author":"Stratton","year":"2016","journal-title":"J Mol Cell Cardiol"},{"issue":"5","key":"10.1016\/j.carpath.2024.107673_bib0011","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1007\/s10741-018-9694-z","article-title":"Epigenetic signatures in cardiac fibrosis, special emphasis on DNA methylation and histone modification","volume":"23","author":"Tao","year":"2018","journal-title":"Heart Fail Rev"},{"key":"10.1016\/j.carpath.2024.107673_bib0012","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.yjmcc.2021.06.003","article-title":"Epigenetic alterations of TGF\u03b2 and its main canonical signaling mediators in the context of cardiac fibrosis","volume":"159","author":"Algeciras","year":"2021","journal-title":"J Mol Cell Cardiol"},{"issue":"2","key":"10.1016\/j.carpath.2024.107673_bib0013","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.jjcc.2016.10.004","article-title":"Evidence of epigenetic tags in cardiac fibrosis","volume":"69","author":"Grimaldi","year":"2017","journal-title":"J Cardiol"},{"key":"10.1016\/j.carpath.2024.107673_bib0014","doi-asserted-by":"crossref","DOI":"10.1177\/2040622319862697","article-title":"HDAC inhibitors as antifibrotic drugs in cardiac and pulmonary fibrosis","volume":"10","author":"Lyu","year":"2019","journal-title":"Ther Adv Chronic Dis"},{"issue":"8","key":"10.1016\/j.carpath.2024.107673_bib0015","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1038\/nrg.2016.59","article-title":"The molecular hallmarks of epigenetic control","volume":"17","author":"Allis","year":"2016","journal-title":"Nat Rev Genet"},{"issue":"3","key":"10.1016\/j.carpath.2024.107673_bib0016","first-page":"868","article-title":"The dietary compound curcumin inhibits p300 histone acetyltransferase activity and prevents heart failure in rats","volume":"118","author":"Morimoto","year":"2008","journal-title":"J Clin Invest"},{"issue":"1","key":"10.1016\/j.carpath.2024.107673_bib0017","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1186\/1475-2840-13-89","article-title":"High glucose induces Smad activation via the transcriptional coregulator p300 and contributes to cardiac fibrosis and hypertrophy","volume":"13","author":"Bugyei-Twum","year":"2014","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"10.1016\/j.carpath.2024.107673_bib0018","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1002\/biof.1065","article-title":"Molecular mechanisms of curcumin action: signal transduction","volume":"39","author":"Shehzad","year":"2013","journal-title":"Biofactors"},{"issue":"11","key":"10.1016\/j.carpath.2024.107673_bib0019","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1080\/15592294.2017.1370173","article-title":"A novel acetyltransferase p300 inhibitor ameliorates hypertension-associated cardio-renal fibrosis","volume":"12","author":"Rai","year":"2017","journal-title":"Epigenetics"},{"issue":"4","key":"10.1016\/j.carpath.2024.107673_bib0020","doi-asserted-by":"crossref","first-page":"3026","DOI":"10.1111\/jcmm.14162","article-title":"Acetyltransferase p300 inhibitor reverses hypertension-induced cardiac fibrosis","volume":"23","author":"Rai","year":"2019","journal-title":"J Cell Mol Med"},{"issue":"11","key":"10.1016\/j.carpath.2024.107673_bib0021","doi-asserted-by":"crossref","first-page":"2839","DOI":"10.3390\/cells10112839","article-title":"Acetyltransferase p300 is a putative epidrug target for amelioration of cellular aging-related cardiovascular disease","volume":"10","author":"Ghosh","year":"2021","journal-title":"Cells"},{"issue":"5","key":"10.1016\/j.carpath.2024.107673_bib0022","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1021\/acsmedchemlett.0c00654","article-title":"Discovery of a potent and selective covalent p300\/CBP inhibitor","volume":"12","author":"Mastracchio","year":"2021","journal-title":"ACS Med Chem Lett"},{"issue":"48","key":"10.1016\/j.carpath.2024.107673_bib0023","doi-asserted-by":"crossref","first-page":"3404","DOI":"10.1093\/eurheartj\/ehv290","article-title":"Protective effects of sirtuins in cardiovascular diseases: from bench to bedside","volume":"36","author":"Winnik","year":"2015","journal-title":"Eur Heart J"},{"issue":"10","key":"10.1016\/j.carpath.2024.107673_bib0024","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1161\/01.RES.0000267723.65696.4a","article-title":"Sirt1 regulates aging and resistance to oxidative stress in the heart","volume":"100","author":"Alcendor","year":"2007","journal-title":"Circ Res"},{"issue":"12","key":"10.1016\/j.carpath.2024.107673_bib0025","doi-asserted-by":"crossref","first-page":"914","DOI":"10.18632\/aging.100252","article-title":"Regulation of the mPTP by SIRT3-mediated deacetylation of CypD at lysine 166 suppresses age-related cardiac hypertrophy","volume":"2","author":"Hafner","year":"2010","journal-title":"Aging (Albany NY)"},{"key":"10.1016\/j.carpath.2024.107673_bib0026","first-page":"1267","article-title":"Curcumin protects against myocardial infarction-induced cardiac fibrosis via SIRT1 activation in vivo and in vitro","volume":"10","author":"Xiao","year":"2016","journal-title":"Drug Des Devel Ther"},{"issue":"9","key":"10.1016\/j.carpath.2024.107673_bib0027","doi-asserted-by":"crossref","first-page":"12334","DOI":"10.18632\/aging.203027","article-title":"The nuclear sirtuin SIRT6 protects the heart from developing aging-associated myocyte senescence and cardiac hypertrophy","volume":"13","author":"Pillai","year":"2021","journal-title":"Aging (Albany NY)"},{"issue":"12","key":"10.1016\/j.carpath.2024.107673_bib0028","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1093\/cvr\/cvy131","article-title":"Sirtuin 1 activation attenuates cardiac fibrosis in a rodent pressure overload model by modifying Smad2\/3 transactivation","volume":"114","author":"Bugyei-Twum","year":"2018","journal-title":"Cardiovasc Res"},{"issue":"1","key":"10.1016\/j.carpath.2024.107673_bib0029","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1038\/s41392-020-0114-1","article-title":"SIRT3-mediated inhibition of FOS through histone H3 deacetylation prevents cardiac fibrosis and inflammation","volume":"5","author":"Palomer","year":"2020","journal-title":"Signal Transduct Target Ther"},{"issue":"1","key":"10.1016\/j.carpath.2024.107673_bib0030","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/s12872-021-02401-y","article-title":"Resveratrol ameliorates myocardial fibrosis by regulating Sirt1\/Smad3 deacetylation pathway in rat model with dilated cardiomyopathy","volume":"22","author":"Chen","year":"2022","journal-title":"BMC Cardiovasc Disord"},{"key":"10.1016\/j.carpath.2024.107673_bib0031","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2019.109227","article-title":"SIRT1 activation attenuates cardiac fibrosis by endothelial-to-mesenchymal transition","volume":"118","author":"Liu","year":"2019","journal-title":"Biomed Pharmacother"},{"issue":"21","key":"10.1016\/j.carpath.2024.107673_bib0032","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.1161\/CIRCULATIONAHA.117.028728","article-title":"SIRT2 acts as a cardioprotective deacetylase in pathological cardiac hypertrophy","volume":"136","author":"Tang","year":"2017","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.carpath.2024.107673_bib0033","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1161\/CIRCRESAHA.109.209338","article-title":"Protein acetylation in the cardiorenal axis: the promise of histone deacetylase inhibitors","volume":"106","author":"Bush","year":"2010","journal-title":"Circ Res"},{"issue":"4","key":"10.1016\/j.carpath.2024.107673_bib0034","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.yjmcc.2010.11.009","article-title":"Isoform-selective HDAC inhibitors: closing in on translational medicine for the heart","volume":"51","author":"McKinsey","year":"2011","journal-title":"J Mol Cell Cardiol"},{"key":"10.1016\/j.carpath.2024.107673_bib0035","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.yjmcc.2013.12.013","article-title":"Class I HDACs regulate angiotensin II-dependent cardiac fibrosis via fibroblasts and circulating fibrocytes","volume":"67","author":"Williams","year":"2014","journal-title":"J Mol Cell Cardiol"},{"issue":"1","key":"10.1016\/j.carpath.2024.107673_bib0036","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1755-1536-7-10","article-title":"HDAC class I inhibitor, mocetinostat, reverses cardiac fibrosis in heart failure and diminishes CD90+ cardiac myofibroblast activation","volume":"7","author":"Nural-Guvener","year":"2014","journal-title":"Fibrogenesis Tissue Repair"},{"issue":"11","key":"10.1016\/j.carpath.2024.107673_bib0037","doi-asserted-by":"crossref","first-page":"H1391","DOI":"10.1152\/ajpheart.00390.2014","article-title":"Inhibition of class I histone deacetylase activity represses matrix metalloproteinase-2 and-9 expression and preserves LV function postmyocardial infarction","volume":"308","author":"Mani","year":"2015","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"9","key":"10.1016\/j.carpath.2024.107673_bib0038","doi-asserted-by":"crossref","first-page":"5249","DOI":"10.1111\/jcmm.15178","article-title":"Overexpression of peptidase inhibitor 16 attenuates angiotensin II\u2013induced cardiac fibrosis via regulating HDAC1 of cardiac fibroblasts","volume":"24","author":"Deng","year":"2020","journal-title":"J Cell Mol Med"},{"issue":"3","key":"10.1016\/j.carpath.2024.107673_bib0039","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0213186","article-title":"Class I histone deacetylase inhibitor MS-275 attenuates vasoconstriction and inflammation in angiotensin II-induced hypertension","volume":"14","author":"Ryu","year":"2019","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.carpath.2024.107673_bib0040","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1161\/CIRCRESAHA.120.317254","article-title":"Epigenomes of human hearts reveal new genetic variants relevant for cardiac disease and phenotype","volume":"127","author":"Tan","year":"2020","journal-title":"Circ Res"},{"issue":"7327","key":"10.1016\/j.carpath.2024.107673_bib0041","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1038\/nature09504","article-title":"Selective inhibition of BET bromodomains","volume":"468","author":"Filippakopoulos","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.carpath.2024.107673_bib0042","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.yjmcc.2013.07.017","article-title":"BET acetyl-lysine binding proteins control pathological cardiac hypertrophy","volume":"63","author":"Spiltoir","year":"2013","journal-title":"J Mol Cell Cardiol"},{"key":"10.1016\/j.carpath.2024.107673_bib0043","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.yjmcc.2018.12.002","article-title":"Inhibition of BRD4 attenuates transverse aortic constriction- and TGF-\u03b2-induced endothelial-mesenchymal transition and cardiac fibrosis","volume":"127","author":"Song","year":"2019","journal-title":"J Mol Cell Cardiol"},{"issue":"15","key":"10.1016\/j.carpath.2024.107673_bib0044","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.138687","article-title":"BET bromodomain proteins regulate transcriptional reprogramming in genetic dilated cardiomyopathy","volume":"5","author":"Antolic","year":"2020","journal-title":"JCI Insight"},{"issue":"390","key":"10.1016\/j.carpath.2024.107673_bib0045","doi-asserted-by":"crossref","first-page":"eaah5084","DOI":"10.1126\/scitranslmed.aah5084","article-title":"BET bromodomain inhibition suppresses innate inflammatory and profibrotic transcriptional networks in heart failure","volume":"9","author":"Duan","year":"2017","journal-title":"Sci Transl Med"},{"issue":"7","key":"10.1016\/j.carpath.2024.107673_bib0046","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1161\/CIRCRESAHA.119.315125","article-title":"Dynamic chromatin targeting of BRD4 stimulates cardiac fibroblast activation","volume":"125","author":"Stratton","year":"2019","journal-title":"Circ Res"},{"issue":"7867","key":"10.1016\/j.carpath.2024.107673_bib0047","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1038\/s41586-021-03674-1","article-title":"A transcriptional switch governs fibroblast activation in heart disease","volume":"595","author":"Alexanian","year":"2021","journal-title":"Nature"},{"issue":"6","key":"10.1016\/j.carpath.2024.107673_bib0048","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1164\/rccm.201201-0077OC","article-title":"Altered DNA methylation profile in idiopathic pulmonary fibrosis","volume":"186","author":"Sanders","year":"2012","journal-title":"Am J Respir Crit Care Med"},{"issue":"5","key":"10.1016\/j.carpath.2024.107673_bib0049","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1038\/nm.2135","article-title":"Methylation determines fibroblast activation and fibrogenesis in the kidney","volume":"16","author":"Bechtel","year":"2010","journal-title":"Nat Med"},{"issue":"5","key":"10.1016\/j.carpath.2024.107673_bib0050","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1165\/rcmb.2007-0322OC","article-title":"Thy-1 promoter hypermethylation: a novel epigenetic pathogenic mechanism in pulmonary fibrosis","volume":"39","author":"Sanders","year":"2008","journal-title":"Am J Respir Cell Mol Biol"},{"issue":"11","key":"10.1016\/j.carpath.2024.107673_bib0051","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1136\/gutjnl-2015-311292","article-title":"Epigenetics in liver disease: from biology to therapeutics","volume":"65","author":"Hardy","year":"2016","journal-title":"Gut"},{"key":"10.1016\/j.carpath.2024.107673_bib0052","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.tox.2014.06.006","article-title":"DNMT3A silencing RASSF1A promotes cardiac fibrosis through upregulation of ERK1\/2","volume":"323","author":"Tao","year":"2014","journal-title":"Toxicology"},{"key":"10.1016\/j.carpath.2024.107673_bib0053","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.yjmcc.2015.03.007","article-title":"Experimental heart failure modelled by the cardiomyocyte-specific loss of an epigenome modifier, DNMT3B","volume":"82","author":"Vujic","year":"2015","journal-title":"J Mol Cell Cardiol"},{"issue":"6","key":"10.1016\/j.carpath.2024.107673_bib0054","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1161\/CIRCULATIONAHA.111.056952","article-title":"Proteomics analysis of cardiac extracellular matrix remodeling in a porcine model of ischemia\/reperfusion injury","volume":"125","author":"Barallobre-Barreiro","year":"2012","journal-title":"Circulation"},{"issue":"8","key":"10.1016\/j.carpath.2024.107673_bib0055","doi-asserted-by":"crossref","first-page":"2176","DOI":"10.1093\/hmg\/ddt614","article-title":"Hypoxia-induced epigenetic modifications are associated with cardiac tissue fibrosis and the development of a myofibroblast-like phenotype","volume":"23","author":"Watson","year":"2014","journal-title":"Hum Mol Genet"},{"issue":"5","key":"10.1016\/j.carpath.2024.107673_bib0056","doi-asserted-by":"crossref","first-page":"3481","DOI":"10.1002\/jcp.30078","article-title":"DNMT1 deregulation of SOCS3 axis drives cardiac fibroblast activation in diabetic cardiac fibrosis","volume":"236","author":"Tao","year":"2021","journal-title":"J Cell Physiol"},{"issue":"12","key":"10.1016\/j.carpath.2024.107673_bib0057","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1007\/s12012-021-09690-x","article-title":"DNMT1-Induced miR-152-3p suppression facilitates cardiac fibroblast activation in cardiac fibrosis","volume":"21","author":"Xu","year":"2021","journal-title":"Cardiovasc Toxicol"},{"issue":"3","key":"10.1016\/j.carpath.2024.107673_bib0058","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1007\/s10753-020-01191-3","article-title":"DNMT1 methylation of LncRNA GAS5 leads to cardiac fibroblast pyroptosis via affecting NLRP3 axis","volume":"43","author":"She","year":"2020","journal-title":"Inflammation"},{"issue":"5","key":"10.1016\/j.carpath.2024.107673_bib0059","doi-asserted-by":"crossref","first-page":"7174","DOI":"10.1002\/jcp.27471","article-title":"DNA methylation regulates \u03b1-smooth muscle actin expression during cardiac fibroblast differentiation","volume":"234","author":"He","year":"2019","journal-title":"J Cell Physiol"},{"issue":"7","key":"10.1016\/j.carpath.2024.107673_bib0060","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1038\/s41374-020-0402-y","article-title":"Myocardial tissue-specific Dnmt1 knockout in rats protects against pathological injury induced by adriamycin","volume":"100","author":"Wu","year":"2020","journal-title":"Lab Invest"},{"issue":"3","key":"10.1016\/j.carpath.2024.107673_bib0061","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1161\/CIRCRESAHA.118.313225","article-title":"CRISPR-mediated gene editing to assess the roles of Tet2 and Dnmt3a in clonal hematopoiesis and cardiovascular disease","volume":"123","author":"Sano","year":"2018","journal-title":"Circ Res"},{"issue":"1","key":"10.1016\/j.carpath.2024.107673_bib0062","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1177\/1074248415591698","article-title":"Epigenetic therapy for the treatment of hypertension-induced cardiac hypertrophy and fibrosis","volume":"21","author":"Watson","year":"2015","journal-title":"J Cardiovasc Pharmacol Ther"},{"issue":"4","key":"10.1016\/j.carpath.2024.107673_bib0063","doi-asserted-by":"crossref","first-page":"e60335","DOI":"10.1371\/journal.pone.0060335","article-title":"Transforming growth factor \u03b21 induces the expression of collagen type I by DNA methylation in cardiac fibroblasts","volume":"8","author":"Pan","year":"2013","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.carpath.2024.107673_bib0064","doi-asserted-by":"crossref","first-page":"e324","DOI":"10.1038\/emm.2017.11","article-title":"Writing, erasing and reading histone lysine methylations","volume":"49","author":"Hyun","year":"2017","journal-title":"Exp Mol Med"},{"key":"10.1016\/j.carpath.2024.107673_bib0065","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.yjmcc.2021.05.018","article-title":"The role of demethylases in cardiac development and disease","volume":"158","author":"Davis","year":"2021","journal-title":"J Mol Cell Cardiol"},{"key":"10.1016\/j.carpath.2024.107673_bib0066","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.yjmcc.2019.11.107","article-title":"Cardiac-specific inactivation of LSD1 in mice leads to myocardial hypertrophy and heart failure","volume":"140","author":"Huo","year":"2020","journal-title":"J Mol Cell Cardiol"},{"key":"10.1016\/j.carpath.2024.107673_bib0067","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.yjmcc.2018.01.006","article-title":"Riboflavin attenuates myocardial injury via LSD1-mediated crosstalk between phospholipid metabolism and histone methylation in mice with experimental myocardial infarction","volume":"115","author":"Wang","year":"2018","journal-title":"J Mol Cell Cardiol"},{"issue":"3","key":"10.1016\/j.carpath.2024.107673_bib0068","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1161\/CIRCRESAHA.120.318149","article-title":"Myofibroblast deficiency of LSD1 alleviates TAC-induced heart failure","volume":"129","author":"Huo","year":"2021","journal-title":"Circ Res"},{"issue":"2","key":"10.1016\/j.carpath.2024.107673_bib0069","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1038\/nm.3777","article-title":"Orphan nuclear receptor NR4A1 regulates transforming growth factor-\u03b2 signaling and fibrosis","volume":"21","author":"Palumbo-Zerr","year":"2015","journal-title":"Nat Med"},{"issue":"1","key":"10.1016\/j.carpath.2024.107673_bib0070","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41467-018-07173-2","article-title":"Histone lysine dimethyl-demethylase KDM3A controls pathological cardiac hypertrophy and fibrosis","volume":"9","author":"Zhang","year":"2018","journal-title":"Nat Commun"},{"issue":"3","key":"10.1016\/j.carpath.2024.107673_bib0071","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1172\/JCI61084","article-title":"HDAC4 controls histone methylation in response to elevated cardiac load","volume":"123","author":"Hohl","year":"2013","journal-title":"J Clin Invest"},{"issue":"4","key":"10.1016\/j.carpath.2024.107673_bib0072","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1080\/10799893.2020.1734819","article-title":"Inhibition of histone demethylase JMJD1C attenuates cardiac hypertrophy and fibrosis induced by angiotensin II","volume":"40","author":"Zhang","year":"2020","journal-title":"J Recept Signal Transduct Res"},{"issue":"6","key":"10.1016\/j.carpath.2024.107673_bib0073","doi-asserted-by":"crossref","first-page":"2447","DOI":"10.1172\/JCI46277","article-title":"The histone trimethyllysine demethylase JMJD2A promotes cardiac hypertrophy in response to hypertrophic stimuli in mice","volume":"121","author":"Zhang","year":"2011","journal-title":"J Clin Invest"},{"key":"10.1016\/j.carpath.2024.107673_bib0074","doi-asserted-by":"crossref","first-page":"14","DOI":"10.3389\/fgene.2018.00014","article-title":"The Histone demethylase JMJD2A modulates the induction of hypertrophy markers in iPSC-derived cardiomyocytes","volume":"9","author":"Rosales","year":"2018","journal-title":"Front Genet"},{"key":"10.1016\/j.carpath.2024.107673_bib0075","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.mce.2018.05.009","article-title":"JMJD3 inhibition protects against isoproterenol-induced cardiac hypertrophy by suppressing \u03b2-MHC expression","volume":"477","author":"Guo","year":"2018","journal-title":"Mol Cell Endocrinol"},{"issue":"1","key":"10.1016\/j.carpath.2024.107673_bib0076","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.yexcr.2015.04.012","article-title":"The histone demethylase PHF8 represses cardiac hypertrophy upon pressure overload","volume":"335","author":"Liu","year":"2015","journal-title":"Exp Cell Res"},{"issue":"5","key":"10.1016\/j.carpath.2024.107673_bib0077","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1007\/s00412-009-0221-9","article-title":"DNA methylation and methyl-CpG binding proteins: developmental requirements and function","volume":"118","author":"Bogdanovi\u0107","year":"2009","journal-title":"Chromosoma"},{"issue":"2","key":"10.1016\/j.carpath.2024.107673_bib0078","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1053\/j.gastro.2009.10.002","article-title":"MeCP2 controls an epigenetic pathway that promotes myofibroblast transdifferentiation and fibrosis","volume":"138","author":"Mann","year":"2010","journal-title":"Gastroenterology"},{"issue":"7","key":"10.1016\/j.carpath.2024.107673_bib0079","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1161\/CIRCRESAHA.115.306721","article-title":"Adrenergic repression of the epigenetic reader MeCP2 facilitates cardiac adaptation in chronic heart failure","volume":"117","author":"Mayer","year":"2015","journal-title":"Circ Res"},{"issue":"24","key":"10.1016\/j.carpath.2024.107673_bib0080","doi-asserted-by":"crossref","first-page":"9806","DOI":"10.1073\/pnas.1301509110","article-title":"Signal-dependent repression of DUSP5 by class I HDACs controls nuclear ERK activity and cardiomyocyte hypertrophy","volume":"110","author":"Ferguson","year":"2013","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.carpath.2024.107673_bib0081","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.ijbiomac.2015.10.076","article-title":"MeCP2 regulation of cardiac fibroblast proliferation and fibrosis by down-regulation of DUSP5","volume":"82","author":"Tao","year":"2016","journal-title":"Int J Biol Macromol"},{"issue":"9","key":"10.1016\/j.carpath.2024.107673_bib0082","doi-asserted-by":"crossref","first-page":"2389","DOI":"10.1016\/j.bbadis.2017.05.010","article-title":"DNA methylation regulated gene expression in organ fibrosis","volume":"1863","author":"Zhang","year":"2017","journal-title":"Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease"},{"issue":"1","key":"10.1016\/j.carpath.2024.107673_bib0083","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1186\/s13148-019-0776-0","article-title":"The timeline of epigenetic drug discovery: from reality to dreams","volume":"11","author":"Ganesan","year":"2019","journal-title":"Clin Epigenetics"},{"issue":"5","key":"10.1016\/j.carpath.2024.107673_bib0084","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/j.stemcr.2014.04.006","article-title":"Exosomes as critical agents of cardiac regeneration triggered by cell therapy","volume":"2","author":"Ibrahim","year":"2014","journal-title":"Stem Cell Rep"},{"issue":"2","key":"10.1016\/j.carpath.2024.107673_bib0085","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1161\/CIRCRESAHA.115.307654","article-title":"More than tiny sacks: stem cell exosomes as cell-free modality for cardiac repair","volume":"118","author":"Kishore","year":"2016","journal-title":"Circ Res"},{"key":"10.1016\/j.carpath.2024.107673_bib0086","doi-asserted-by":"crossref","first-page":"318","DOI":"10.3389\/fcell.2019.00318","article-title":"Cardiac fibroblasts and cardiac fibrosis: precise role of exosomes","volume":"7","author":"Ranjan","year":"2019","journal-title":"Front Cell Dev Biol"},{"issue":"29","key":"10.1016\/j.carpath.2024.107673_bib0087","doi-asserted-by":"crossref","first-page":"2704","DOI":"10.1093\/eurheartj\/ehx165","article-title":"Non-coding RNAs in cardiovascular diseases: diagnostic and therapeutic perspectives","volume":"39","author":"Poller","year":"2018","journal-title":"Eur Heart J"},{"issue":"8","key":"10.1016\/j.carpath.2024.107673_bib0088","doi-asserted-by":"crossref","first-page":"106","DOI":"10.4252\/wjsc.v10.i8.106","article-title":"Stem cell-derived exosomes-an emerging tool for myocardial regeneration","volume":"10","author":"Lazar","year":"2018","journal-title":"World J Stem Cells"},{"key":"10.1016\/j.carpath.2024.107673_bib0089","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2021.767488","article-title":"Exosomes in cardiovascular diseases: pathological potential of nano-messenger","volume":"8","author":"Jadli","year":"2021","journal-title":"Front Cardiovasc Med"},{"issue":"7","key":"10.1016\/j.carpath.2024.107673_bib0090","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1002\/cbin.11515","article-title":"Reviewing the role of cardiac exosomes in myocardial repair at a glance","volume":"45","author":"Koohsarian","year":"2021","journal-title":"Cell Biol Int"},{"issue":"1","key":"10.1016\/j.carpath.2024.107673_bib0091","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1021\/acsnano.3c09368","article-title":"Biomimetic cardiac fibrosis-on-a-chip as a visible disease model for evaluating mesenchymal stem cell-derived exosome therapy","volume":"18","author":"Shang","year":"2024","journal-title":"ACS Nano"},{"issue":"6","key":"10.1016\/j.carpath.2024.107673_bib0092","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.1021\/acsbiomaterials.1c00217","article-title":"Potential use of exosomes as diagnostic biomarkers and in targeted drug delivery: progress in clinical and preclinical applications","volume":"7","author":"Huda","year":"2021","journal-title":"ACS Biomater Sci Eng"},{"issue":"5","key":"10.1016\/j.carpath.2024.107673_bib0093","doi-asserted-by":"crossref","first-page":"769","DOI":"10.2217\/bmm.13.63","article-title":"Exosomes: The future of biomarkers in medicine","volume":"7","author":"Properzi","year":"2013","journal-title":"Biomark Med"},{"issue":"6","key":"10.1016\/j.carpath.2024.107673_bib0094","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.114.001249","article-title":"Micro RNA expression in circulating microvesicles predicts cardiovascular events in patients with coronary artery disease","volume":"3","author":"Jansen","year":"2014","journal-title":"J Am Heart Assoc"},{"issue":"11","key":"10.1016\/j.carpath.2024.107673_bib0095","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1016\/j.kjms.2018.05.008","article-title":"Reduced exosome miR-425 and miR-744 in the plasma represents the progression of fibrosis and heart failure","volume":"34","author":"Wang","year":"2018","journal-title":"Kaohsiung J Med Sci"},{"issue":"1","key":"10.1016\/j.carpath.2024.107673_bib0096","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1161\/CIRCRESAHA.120.317244","article-title":"Mir-30d regulates cardiac remodeling by intracellular and paracrine signaling","volume":"128","author":"Li","year":"2021","journal-title":"Circ Res"},{"key":"10.1016\/j.carpath.2024.107673_bib0097","doi-asserted-by":"crossref","first-page":"93","DOI":"10.21037\/sci.2017.11.06","article-title":"Beneficial effects of exosomes secreted by cardiac-derived progenitor cells and other cell types in myocardial ischemia","volume":"4","author":"Barile","year":"2017","journal-title":"Stem Cell Investig"},{"issue":"4","key":"10.1016\/j.carpath.2024.107673_bib0098","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1002\/stem.2575","article-title":"Concise review: MSC-derived exosomes for cell-free therapy","volume":"35","author":"Phinney","year":"2017","journal-title":"Stem Cells (1981)"},{"key":"10.1016\/j.carpath.2024.107673_bib0099","doi-asserted-by":"crossref","first-page":"4150705","DOI":"10.1155\/2017\/4150705","article-title":"MiRNA-sequence indicates that mesenchymal stem cells and exosomes have similar mechanism to enhance cardiac repair","volume":"2017","author":"Shao","year":"2017","journal-title":"Biomed Res Int"},{"issue":"7","key":"10.1016\/j.carpath.2024.107673_bib0100","doi-asserted-by":"crossref","first-page":"123","DOI":"10.14715\/cmb\/2019.65.7.21","article-title":"Mesenchymal stem cell-derived exosomes improve diabetes mellitus-induced myocardial injury and fibrosis via inhibition of TGF-\u00ce\u00b21\/Smad2 signaling pathway","volume":"65","author":"Lin","year":"2019","journal-title":"Cell Mol Biol (Noisy-le-grand)"},{"issue":"22","key":"10.1016\/j.carpath.2024.107673_bib0101","first-page":"5197","article-title":"Functional roles of exosomes in cardiovascular disorders: a systematic review","volume":"21","author":"Sun","year":"2017","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"1","key":"10.1016\/j.carpath.2024.107673_bib0102","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1186\/s13287-019-1353-3","article-title":"Combinatorial treatment of acute myocardial infarction using stem cells and their derived exosomes resulted in improved heart performance","volume":"10","author":"Huang","year":"2019","journal-title":"Stem Cell Res Ther"},{"issue":"6","key":"10.1016\/j.carpath.2024.107673_bib0103","first-page":"2319","article-title":"Human peripheral blood\u2011derived exosomes for microRNA delivery","volume":"43","author":"Kang","year":"2019","journal-title":"Int J Mol Med"},{"key":"10.1016\/j.carpath.2024.107673_bib0104","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12951-021-00808-5","article-title":"Macrophage migration inhibitory factor facilitates the therapeutic efficacy of mesenchymal stem cells derived exosomes in acute myocardial infarction through upregulating miR-133a-3p","volume":"19","author":"Zhu","year":"2021","journal-title":"J Nanobiotechnology"},{"issue":"7","key":"10.1016\/j.carpath.2024.107673_bib0105","doi-asserted-by":"crossref","first-page":"11099","DOI":"10.1021\/acsnano.1c00628","article-title":"A minimally invasive exosome spray repairs heart after myocardial infarction","volume":"15","author":"Yao","year":"2021","journal-title":"ACS Nano"},{"issue":"13","key":"10.1016\/j.carpath.2024.107673_bib0106","article-title":"Microneedle patch loaded with exosomes containing microRNA-29b prevents cardiac fibrosis after myocardial infarction","volume":"12","author":"Yuan","year":"2023","journal-title":"Adv Healthc Mater"},{"issue":"15","key":"10.1016\/j.carpath.2024.107673_bib0107","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.118.008737","article-title":"Engineered exosomes with ischemic myocardium-targeting peptide for targeted therapy in myocardial infarction","volume":"7","author":"Wang","year":"2018","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.carpath.2024.107673_bib0108","doi-asserted-by":"crossref","first-page":"402","DOI":"10.3389\/fendo.2018.00402","article-title":"Overview of microRNA biogenesis, mechanisms of actions, and circulation","volume":"9","author":"O\u2019Brien","year":"2018","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/j.carpath.2024.107673_bib0109","doi-asserted-by":"crossref","first-page":"giac083","DOI":"10.1093\/gigascience\/giac083","article-title":"A curated human cellular microRNAome based on 196 primary cell types","volume":"11","author":"Patil","year":"2022","journal-title":"Gigascience"},{"issue":"11","key":"10.1016\/j.carpath.2024.107673_bib0110","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1080\/15476286.2016.1236172","article-title":"Toward the promise of microRNAs\u2013enhancing reproducibility and rigor in microRNA research","volume":"13","author":"Witwer","year":"2016","journal-title":"RNA Biol"},{"issue":"1","key":"10.1016\/j.carpath.2024.107673_bib0111","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s40364-021-00272-1","article-title":"miR-21: a non-specific biomarker of all maladies","volume":"9","author":"Jenike","year":"2021","journal-title":"Biomark Res"},{"issue":"7224","key":"10.1016\/j.carpath.2024.107673_bib0112","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1038\/nature07511","article-title":"MicroRNA-21 contributes to myocardial disease by stimulating MAP kinase signalling in fibroblasts","volume":"456","author":"Thum","year":"2008","journal-title":"Nature"},{"issue":"6","key":"10.1016\/j.carpath.2024.107673_bib0113","doi-asserted-by":"crossref","first-page":"2875","DOI":"10.1016\/j.ijcard.2012.07.021","article-title":"Myocardial and circulating levels of microRNA-21 reflect left ventricular fibrosis in aortic stenosis patients","volume":"167","author":"Villar","year":"2013","journal-title":"Int J Cardiol"},{"issue":"2","key":"10.1016\/j.carpath.2024.107673_bib0114","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1161\/ATVBAHA.111.234286","article-title":"Transforming growth factor-\u03b2\u2013induced endothelial-to-mesenchymal transition is partly mediated by microRNA-21","volume":"32","author":"Kumarswamy","year":"2012","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"12","key":"10.1016\/j.carpath.2024.107673_bib0115","doi-asserted-by":"crossref","first-page":"2152","DOI":"10.1016\/j.biocel.2012.08.019","article-title":"A novel reciprocal loop between microRNA-21 and TGF\u03b2RIII is involved in cardiac fibrosis","volume":"44","author":"Liang","year":"2012","journal-title":"Int J Biochem Cell Biol"},{"issue":"1","key":"10.1016\/j.carpath.2024.107673_bib0116","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1093\/cvr\/cvp015","article-title":"MicroRNA expression in response to murine myocardial infarction: miR-21 regulates fibroblast metalloprotease-2 via phosphatase and tensin homologue","volume":"82","author":"Roy","year":"2009","journal-title":"Cardiovasc Res"},{"issue":"1","key":"10.1016\/j.carpath.2024.107673_bib0117","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1111\/jcmm.14800","article-title":"Inhibition of miR-21 alleviated cardiac perivascular fibrosis via repressing EndMT in T1DM","volume":"24","author":"Li","year":"2020","journal-title":"J Cell Mol Med"},{"issue":"7","key":"10.1016\/j.carpath.2024.107673_bib0118","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1016\/S0092-8674(00)80303-7","article-title":"The MAD-related protein Smad7 associates with the TGF\u03b2 receptor and functions as an antagonist of TGF\u03b2 signaling","volume":"89","author":"Hayashi","year":"1997","journal-title":"Cell"},{"issue":"10","key":"10.1016\/j.carpath.2024.107673_bib0119","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1007\/s00380-016-0808-z","article-title":"Rapid atrial pacing induces myocardial fibrosis by down-regulating Smad7 via microRNA-21 in rabbit","volume":"31","author":"He","year":"2016","journal-title":"Heart Vessels"},{"issue":"3","key":"10.1016\/j.carpath.2024.107673_bib0120","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1152\/physiolgenomics.00098.2004","article-title":"Identification and regulation of Sprouty1, a negative inhibitor of the ERK cascade, in the human heart","volume":"18","author":"Huebert","year":"2004","journal-title":"Physiol Genomics"},{"key":"10.1016\/j.carpath.2024.107673_bib0121","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.2147\/JIR.S285714","article-title":"MicroRNA-21 mediates a positive feedback on angiotensin II-induced myofibroblast transformation","volume":"13","author":"Li","year":"2020","journal-title":"J Inflamm Res"},{"issue":"12","key":"10.1016\/j.carpath.2024.107673_bib0122","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1016\/j.cjca.2014.07.747","article-title":"Micro-RNA 21targets dual specific phosphatase 8 to promote collagen synthesis in high glucose\u2013treated primary cardiac fibroblasts","volume":"30","author":"Liu","year":"2014","journal-title":"Can J Cardiol"},{"issue":"32","key":"10.1016\/j.carpath.2024.107673_bib0123","doi-asserted-by":"crossref","first-page":"2184","DOI":"10.1093\/eurheartj\/ehv109","article-title":"Osteopontin is indispensible for AP1-mediated angiotensin II-related miR-21 transcription during cardiac fibrosis","volume":"36","author":"Lorenzen","year":"2015","journal-title":"Eur Heart J"},{"issue":"9","key":"10.1016\/j.carpath.2024.107673_bib0124","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1161\/CIRCRESAHA.108.183426","article-title":"Toward microrna\u2013based therapeutics for heart disease: the sense in antisense","volume":"103","author":"Van Rooij","year":"2008","journal-title":"Circ Res"},{"issue":"11","key":"10.1016\/j.carpath.2024.107673_bib0125","doi-asserted-by":"crossref","first-page":"3912","DOI":"10.1172\/JCI43604","article-title":"Stress-dependent cardiac remodeling occurs in the absence of microRNA-21 in mice","volume":"120","author":"Patrick","year":"2010","journal-title":"J Clin Invest"},{"issue":"17","key":"10.1016\/j.carpath.2024.107673_bib0126","doi-asserted-by":"crossref","first-page":"2227","DOI":"10.1161\/01.CIR.0000066323.15244.54","article-title":"Hypertrophic cardiomyopathy: distribution of disease genes, spectrum of mutations, and implications for a molecular diagnosis strategy","volume":"107","author":"Richard","year":"2003","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.carpath.2024.107673_bib0127","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1161\/CIRCULATIONAHA.104.507699","article-title":"a-myosin heavy chain","volume":"112","author":"Carniel","year":"2005","journal-title":"Circulation"},{"issue":"5","key":"10.1016\/j.carpath.2024.107673_bib0128","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.cardfail.2010.01.002","article-title":"Expression of microRNA-208 is associated with adverse clinical outcomes in human dilated cardiomyopathy","volume":"16","author":"Satoh","year":"2010","journal-title":"J Card Fail"},{"key":"10.1016\/j.carpath.2024.107673_bib0129","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/479123","article-title":"MicroRNA-208a dysregulates apoptosis genes expression and promotes cardiomyocyte apoptosis during ischemia and its silencing improves cardiac function after myocardial infarction","volume":"2015","author":"Tony","year":"2015","journal-title":"Mediat Inflamm"},{"issue":"1","key":"10.1016\/j.carpath.2024.107673_bib0130","doi-asserted-by":"crossref","first-page":"e84188","DOI":"10.1371\/journal.pone.0084188","article-title":"MicroRNA-208a increases myocardial fibrosis via endoglin in volume overloading heart","volume":"9","author":"Wang","year":"2014","journal-title":"PLoS One"},{"issue":"14","key":"10.1016\/j.carpath.2024.107673_bib0131","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1161\/CIRCULATIONAHA.111.030932","article-title":"Therapeutic inhibition of miR-208a improves cardiac function and survival during heart failure","volume":"124","author":"Montgomery","year":"2011","journal-title":"Circulation"},{"issue":"5","key":"10.1016\/j.carpath.2024.107673_bib0132","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/j.cjca.2014.12.026","article-title":"MicroRNA-208a increases myocardial endoglin expression and myocardial fibrosis in acute myocardial infarction","volume":"31","author":"Shyu","year":"2015","journal-title":"Can J Cardiol"},{"issue":"1","key":"10.1016\/j.carpath.2024.107673_bib0133","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/s12933-019-0814-4","article-title":"Early dysregulation of cardiac-specific microRNA-208a is linked to maladaptive cardiac remodelling in diabetic myocardium","volume":"18","author":"Rawal","year":"2019","journal-title":"Cardiovasc Diabetol"},{"issue":"48","key":"10.1016\/j.carpath.2024.107673_bib0134","doi-asserted-by":"crossref","first-page":"18255","DOI":"10.1073\/pnas.0608791103","article-title":"A signature pattern of stress-responsive microRNAs that can evoke cardiac hypertrophy and heart failure","volume":"103","author":"van Rooij","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"10.1016\/j.carpath.2024.107673_bib0135","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1161\/CIRCULATIONAHA.115.018174","article-title":"MiR-125b is critical for fibroblast-to-myofibroblast transition and cardiac fibrosis","volume":"133","author":"Nagpal","year":"2016","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/j.carpath.2024.107673_bib0136","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1093\/cvr\/cvu044","article-title":"MicroRNA-125b protects against myocardial ischaemia\/reperfusion injury via targeting p53-mediated apoptotic signalling and TRAF6","volume":"102","author":"Wang","year":"2014","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.carpath.2024.107673_bib0137","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/7437281","article-title":"miR-155: an important role in inflammation response","volume":"2022","author":"Hu","year":"2022","journal-title":"J Immunol Res"},{"issue":"3","key":"10.1016\/j.carpath.2024.107673_bib0138","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1161\/ATVBAHA.112.300279","article-title":"MicroRNA-126,-145, and-155: a therapeutic triad in atherosclerosis?","volume":"33","author":"Wei","year":"2013","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"4","key":"10.1016\/j.carpath.2024.107673_bib0139","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1161\/CIRCRESAHA.112.267443","article-title":"MicroRNA profiling identifies microRNA-155 as an adverse mediator of cardiac injury and dysfunction during acute viral myocarditis","volume":"111","author":"Corsten","year":"2012","journal-title":"Circ Res"},{"issue":"13","key":"10.1016\/j.carpath.2024.107673_bib0140","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1161\/CIRCULATIONAHA.112.001357","article-title":"Macrophage microRNA-155 promotes cardiac hypertrophy and failure","volume":"128","author":"Heymans","year":"2013","journal-title":"Circulation"},{"issue":"10","key":"10.1016\/j.carpath.2024.107673_bib0141","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1161\/CIRCRESAHA.114.303784","article-title":"Loss of MicroRNA-155 protects the heart from pathological cardiac hypertrophy","volume":"114","author":"Seok","year":"2014","journal-title":"Circ Res"},{"issue":"4","key":"10.1016\/j.carpath.2024.107673_bib0142","doi-asserted-by":"crossref","first-page":"e60161","DOI":"10.1371\/journal.pone.0060161","article-title":"Bone marrow progenitor cell therapy-mediated paracrine regulation of cardiac miRNA-155 modulates fibrotic response in diabetic hearts","volume":"8","author":"Kishore","year":"2013","journal-title":"PLoS One"},{"issue":"18","key":"10.1016\/j.carpath.2024.107673_bib0143","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1161\/CIRCULATIONAHA.115.016327","article-title":"MicroRNA-155 in the heart","volume":"131","author":"Rayner","year":"2015","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.carpath.2024.107673_bib0144","doi-asserted-by":"crossref","first-page":"e00056","DOI":"10.1002\/prp2.56","article-title":"Inhibition of Let-7 microRNA attenuates myocardial remodeling and improves cardiac function postinfarction in mice","volume":"2","author":"Tolonen","year":"2014","journal-title":"Pharmacol Res Perspect"},{"key":"10.1016\/j.carpath.2024.107673_bib0145","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.yjmcc.2016.04.002","article-title":"Inhibition of let-7 augments the recruitment of epicardial cells and improves cardiac function after myocardial infarction","volume":"94","author":"Seeger","year":"2016","journal-title":"J Mol Cell Cardiol"},{"issue":"3","key":"10.1016\/j.carpath.2024.107673_bib0146","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1161\/01.RES.0000257913.42552.23","article-title":"MicroRNAs play an essential role in the development of cardiac hypertrophy","volume":"100","author":"Sayed","year":"2007","journal-title":"Circ Res"},{"key":"10.1016\/j.carpath.2024.107673_bib0147","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.ebiom.2019.08.001","article-title":"MicroRNA let-7-TGFBR3 signalling regulates cardiomyocyte apoptosis after infarction","volume":"46","author":"Chen","year":"2019","journal-title":"EBioMedicine"},{"issue":"4","key":"10.1016\/j.carpath.2024.107673_bib0148","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1161\/HYPERTENSIONAHA.115.05548","article-title":"MicroRNA Let-7i negatively regulates cardiac inflammation and fibrosis","volume":"66","author":"Wang","year":"2015","journal-title":"Hypertension"},{"issue":"1","key":"10.1016\/j.carpath.2024.107673_bib0149","doi-asserted-by":"crossref","first-page":"18351","DOI":"10.1038\/srep18351","article-title":"MicroRNA-214 mediates isoproterenol-induced proliferation and collagen synthesis in cardiac fibroblasts","volume":"5","author":"Sun","year":"2015","journal-title":"Sci Rep"},{"issue":"4","key":"10.1016\/j.carpath.2024.107673_bib0150","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1172\/JCI59327","article-title":"MicroRNA-214 protects the mouse heart from ischemic injury by controlling Ca\u00b2\u207a overload and cell death","volume":"122","author":"Aurora","year":"2012","journal-title":"J Clin Invest"},{"issue":"10","key":"10.1016\/j.carpath.2024.107673_bib0151","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1002\/ar.23396","article-title":"MicroRNA-214 exerts a cardio-protective effect by inhibition of fibrosis","volume":"299","author":"Dong","year":"2016","journal-title":"Anat Rec (Hoboken)"},{"issue":"4","key":"10.1016\/j.carpath.2024.107673_bib0152","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1016\/j.bbrc.2013.05.079","article-title":"MicroRNA-214 provokes cardiac hypertrophy via repression of EZH2","volume":"436","author":"Yang","year":"2013","journal-title":"Biochem Biophys Res Commun"},{"issue":"9","key":"10.1016\/j.carpath.2024.107673_bib0153","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1038\/s41401-020-00563-7","article-title":"MicroRNA-214 contributes to Ang II-induced cardiac hypertrophy by targeting SIRT3 to provoke mitochondrial malfunction","volume":"42","author":"Ding","year":"2021","journal-title":"Acta Pharmacol Sin"},{"issue":"7","key":"10.1016\/j.carpath.2024.107673_bib0154","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1016\/j.biochi.2013.03.010","article-title":"MicroRNA-29 family, a crucial therapeutic target for fibrosis diseases","volume":"95","author":"He","year":"2013","journal-title":"Biochimie"},{"issue":"3","key":"10.1016\/j.carpath.2024.107673_bib0155","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1007\/s40291-016-0253-9","article-title":"MicroRNA-29: a crucial player in fibrotic disease","volume":"21","author":"Deng","year":"2017","journal-title":"Mol Diagn Ther"},{"key":"10.1016\/j.carpath.2024.107673_bib0156","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.omto.2018.12.011","article-title":"A systematic review of miR-29 in cancer","volume":"12","author":"Kwon","year":"2019","journal-title":"Mol Ther Oncolytics"},{"issue":"35","key":"10.1016\/j.carpath.2024.107673_bib0157","doi-asserted-by":"crossref","first-page":"13027","DOI":"10.1073\/pnas.0805038105","article-title":"Dysregulation of microRNAs after myocardial infarction reveals a role of miR-29 in cardiac fibrosis","volume":"105","author":"Van Rooij","year":"2008","journal-title":"Proc Natl Acad Sci"},{"issue":"9","key":"10.1016\/j.carpath.2024.107673_bib0158","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1016\/j.jacc.2013.09.041","article-title":"Circulating miR-29a, among other up-regulated microRNAs, is the only biomarker for both hypertrophy and fibrosis in patients with hypertrophic cardiomyopathy","volume":"63","author":"Roncarati","year":"2014","journal-title":"J Am Coll Cardiol"},{"issue":"5","key":"10.1016\/j.carpath.2024.107673_bib0159","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1161\/HYPERTENSIONAHA.111.00892","article-title":"Nebivolol induces distinct changes in profibrosis microRNA expression compared with atenolol, in salt-sensitive hypertensive rats","volume":"61","author":"Ye","year":"2013","journal-title":"Hypertension"},{"issue":"2","key":"10.1016\/j.carpath.2024.107673_bib0160","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1007\/s12013-014-0269-x","article-title":"Effect of miR-29a inhibition on ventricular hypertrophy induced by pressure overload","volume":"71","author":"Han","year":"2015","journal-title":"Cell Biochem Biophys"},{"issue":"1","key":"10.1016\/j.carpath.2024.107673_bib0161","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1038\/s41467-017-01737-4","article-title":"Cardiac myocyte miR-29 promotes pathological remodeling of the heart by activating Wnt signaling","volume":"8","author":"Sassi","year":"2017","journal-title":"Nat Commun"},{"key":"10.1016\/j.carpath.2024.107673_bib0162","article-title":"MiR-29a Increase in aging may function as a compensatory mechanism against cardiac fibrosis through SERPINH1 downregulation","volume":"8","author":"Rusu-Nastase","year":"2021","journal-title":"Front Cardiovasc Med"},{"key":"10.1016\/j.carpath.2024.107673_bib0163","doi-asserted-by":"crossref","first-page":"170","DOI":"10.3389\/fcvm.2019.00170","article-title":"Differences in microRNA-29 and pro-fibrotic gene expression in mouse and human hypertrophic cardiomyopathy","volume":"6","author":"Liu","year":"2019","journal-title":"Front Cardiovasc Med"},{"issue":"10","key":"10.1016\/j.carpath.2024.107673_bib0164","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1161\/CIRCRESAHA.113.302400","article-title":"Extracellular matrix secretion by cardiac fibroblasts: role of microRNA-29b and microRNA-30c","volume":"113","author":"Abonnenc","year":"2013","journal-title":"Circ Res"},{"issue":"5","key":"10.1016\/j.carpath.2024.107673_bib0165","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1038\/mt.2014.25","article-title":"miR-29b as a therapeutic agent for angiotensin II-induced cardiac fibrosis by targeting TGF-\u03b2\/Smad3 signaling","volume":"22","author":"Zhang","year":"2014","journal-title":"Mol Ther"},{"issue":"9","key":"10.1016\/j.carpath.2024.107673_bib0166","doi-asserted-by":"crossref","DOI":"10.1042\/BSR20201227","article-title":"miR-29b-3p inhibits post-infarct cardiac fibrosis by targeting FOS","volume":"40","author":"Xue","year":"2020","journal-title":"Biosci Rep"},{"issue":"12","key":"10.1016\/j.carpath.2024.107673_bib0167","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0244065","article-title":"A strategic expression method of miR-29b and its anti-fibrotic effect based on RNA-sequencing analysis","volume":"15","author":"Fan","year":"2020","journal-title":"PLoS One"},{"issue":"9","key":"10.1016\/j.carpath.2024.107673_bib0168","doi-asserted-by":"crossref","first-page":"2441","DOI":"10.1016\/j.bbadis.2019.06.004","article-title":"The Smad3-miR-29b\/miR-29c axis mediates the protective effect of macrophage migration inhibitory factor against cardiac fibrosis","volume":"1865","author":"Liang","year":"2019","journal-title":"Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease"},{"issue":"2","key":"10.1016\/j.carpath.2024.107673_bib0169","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1161\/CIRCRESAHA.108.182535","article-title":"miR-133 and miR-30 regulate connective tissue growth factor: implications for a role of microRNAs in myocardial matrix remodeling","volume":"104","author":"Duisters","year":"2009","journal-title":"Circ Res"},{"issue":"2","key":"10.1016\/j.carpath.2024.107673_bib0170","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1002\/jcp.22939","article-title":"MiR-133a regulates collagen 1A1: potential role of miR-133a in myocardial fibrosis in angiotensin II-dependent hypertension","volume":"227","author":"Castoldi","year":"2012","journal-title":"J Cell Physiol"},{"issue":"9","key":"10.1016\/j.carpath.2024.107673_bib0171","doi-asserted-by":"crossref","first-page":"e44744","DOI":"10.1371\/journal.pone.0044744","article-title":"Global microRNA profiling of the mouse ventricles during development of severe hypertrophic cardiomyopathy and heart failure","volume":"7","author":"Bagnall","year":"2012","journal-title":"PLoS One"},{"issue":"24","key":"10.1016\/j.carpath.2024.107673_bib0172","doi-asserted-by":"crossref","first-page":"1973","DOI":"10.1161\/CIRCULATIONAHA.121.055866","article-title":"Nano-miR-133a replacement therapy blunts pressure overload induced heart failure","volume":"144","author":"Modica","year":"2021","journal-title":"Circulation"},{"issue":"5","key":"10.1016\/j.carpath.2024.107673_bib0173","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1161\/CIRCRESAHA.116.309528","article-title":"MicroRNA-33 controls adaptive fibrotic response in the remodeling heart by preserving lipid raft cholesterol","volume":"120","author":"Nishiga","year":"2017","journal-title":"Circ Res"},{"issue":"1","key":"10.1016\/j.carpath.2024.107673_bib0174","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1161\/CIRCRESAHA.109.202176","article-title":"MicroRNA-133a protects against myocardial fibrosis and modulates electrical repolarization without affecting hypertrophy in pressure-overloaded adult hearts","volume":"106","author":"Matkovich","year":"2010","journal-title":"Circ Res"},{"issue":"3","key":"10.1016\/j.carpath.2024.107673_bib0175","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1111\/1755-5922.12113","article-title":"miR-30c mediates upregulation of Cdc42 and Pak1 in diabetic cardiomyopathy","volume":"33","author":"Raut","year":"2015","journal-title":"Cardiovasc Ther"},{"issue":"8","key":"10.1016\/j.carpath.2024.107673_bib0176","doi-asserted-by":"crossref","first-page":"e44532","DOI":"10.1371\/journal.pone.0044532","article-title":"miR-421 and miR-30c inhibit SERPINE 1 gene expression in human endothelial cells","volume":"7","author":"Marchand","year":"2012","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.carpath.2024.107673_bib0177","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1159\/000445568","article-title":"MicroRNA-150 inhibits the activation of cardiac fibroblasts by regulating c-Myb","volume":"38","author":"Deng","year":"2016","journal-title":"Cell Physiol Biochem"},{"issue":"6","key":"10.1016\/j.carpath.2024.107673_bib0178","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1016\/j.amjcard.2013.11.060","article-title":"Relation of reduced expression of MiR-150 in platelets to atrial fibrillation in patients with chronic systolic heart failure","volume":"113","author":"Goren","year":"2014","journal-title":"Am J Cardiol"},{"issue":"3","key":"10.1016\/j.carpath.2024.107673_bib0179","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.healun.2013.10.014","article-title":"MicroRNA-150 inhibits expression of adiponectin receptor 2 and is a potential therapeutic target in patients with chronic heart failure","volume":"33","author":"Kreth","year":"2014","journal-title":"J Heart Lung Transplant"},{"issue":"3","key":"10.1016\/j.carpath.2024.107673_bib0180","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1161\/CIRCGENETICS.113.000077","article-title":"MicroRNA-150: a novel marker of left ventricular remodeling after acute myocardial infarction","volume":"6","author":"Devaux","year":"2013","journal-title":"Circ Cardiovasc Genet"},{"issue":"10","key":"10.1016\/j.carpath.2024.107673_bib0181","doi-asserted-by":"crossref","first-page":"2166","DOI":"10.1002\/jcb.25057","article-title":"MicroRNA-150 protects against pressure overload-induced cardiac hypertrophy","volume":"116","author":"Liu","year":"2015","journal-title":"J Cell Biochem"},{"issue":"11","key":"10.1016\/j.carpath.2024.107673_bib0182","doi-asserted-by":"crossref","first-page":"7769","DOI":"10.1002\/jcp.29386","article-title":"Inhibition of microRNA-150-5p alleviates cardiac inflammation and fibrosis via targeting Smad7 in high glucose-treated cardiac fibroblasts","volume":"235","author":"Che","year":"2020","journal-title":"J Cell Physiol"},{"issue":"18","key":"10.1016\/j.carpath.2024.107673_bib0183","doi-asserted-by":"crossref","first-page":"e150405","DOI":"10.1172\/jci.insight.150405","article-title":"Cardiomyocyte microRNA-150 confers cardiac protection and directly represses proapoptotic small proline-rich protein 1A","volume":"6","author":"Aonuma","year":"2021","journal-title":"JCI Insight"},{"issue":"4","key":"10.1016\/j.carpath.2024.107673_bib0184","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.121.008686","article-title":"MiR-150 attenuates maladaptive cardiac remodeling mediated by long noncoding RNA MIAT and directly represses profibrotic hoxa4","volume":"15","author":"Aonuma","year":"2022","journal-title":"Circ Heart Fail"},{"issue":"1","key":"10.1016\/j.carpath.2024.107673_bib0185","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1161\/CIRCGENETICS.114.000598","article-title":"MicroRNA-150 protects the heart from injury by inhibiting monocyte accumulation in a mouse model of acute myocardial infarction","volume":"8","author":"Liu","year":"2015","journal-title":"Circ Cardiovasc Genet"},{"issue":"5","key":"10.1016\/j.carpath.2024.107673_bib0186","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1161\/CIRCRESAHA.114.302766","article-title":"\u03b2-arrestin1\u2013biased \u03b21-adrenergic receptor signaling regulates microRNA processing","volume":"114","author":"Kim","year":"2014","journal-title":"Circ Res"},{"issue":"2","key":"10.1016\/j.carpath.2024.107673_bib0187","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.cell.2007.03.030","article-title":"Dysregulation of cardiogenesis, cardiac conduction, and cell cycle in mice lacking miRNA-1-2","volume":"129","author":"Zhao","year":"2007","journal-title":"Cell"},{"issue":"3","key":"10.1016\/j.carpath.2024.107673_bib0188","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1152\/physiolgenomics.00144.2007","article-title":"Altered microRNA expression in human heart disease","volume":"31","author":"Ikeda","year":"2007","journal-title":"Physiol Genomics"},{"key":"10.1016\/j.carpath.2024.107673_bib0189","doi-asserted-by":"crossref","first-page":"65","DOI":"10.3389\/fcvm.2019.00065","article-title":"MicroRNA-1-mediated inhibition of cardiac fibroblast proliferation through targeting cyclin D2 and CDK6","volume":"6","author":"Valkov","year":"2019","journal-title":"Front Cardiovasc Med"},{"issue":"14","key":"10.1016\/j.carpath.2024.107673_bib0190","doi-asserted-by":"crossref","first-page":"2444","DOI":"10.1242\/jcs.067165","article-title":"Attenuation of microRNA-1 derepresses the cytoskeleton regulatory protein twinfilin-1 to provoke cardiac hypertrophy","volume":"123","author":"Li","year":"2010","journal-title":"J Cell Sci"},{"issue":"2","key":"10.1016\/j.carpath.2024.107673_bib0191","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.113.000078","article-title":"Therapeutic cardiac-targeted delivery of miR-1 reverses pressure overload\u2013induced cardiac hypertrophy and attenuates pathological remodeling","volume":"2","author":"Karakikes","year":"2013","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.carpath.2024.107673_bib0192","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.ijcard.2019.09.050","article-title":"Value of circulating miRNA-1 detected within 3 h after the onset of acute chest pain in the diagnosis and prognosis of acute myocardial infarction","volume":"307","author":"Su","year":"2020","journal-title":"Int J Cardiol"},{"issue":"11","key":"10.1016\/j.carpath.2024.107673_bib0193","doi-asserted-by":"crossref","first-page":"2284","DOI":"10.1111\/j.1582-4934.2011.01449.x","article-title":"Experimental acute myocardial infarction: telocytes involvement in neo-angiogenesis","volume":"15","author":"Manole","year":"2011","journal-title":"J Cell Mol Med"},{"key":"10.1016\/j.carpath.2024.107673_bib0194","doi-asserted-by":"crossref","DOI":"10.1016\/j.abb.2020.108405","article-title":"MicroRNA-27 attenuates pressure overload-Induced cardiac hypertrophy and dysfunction by targeting galectin-3","volume":"689","author":"Zhang","year":"2020","journal-title":"Arch Biochem Biophys"},{"issue":"24","key":"10.1016\/j.carpath.2024.107673_bib0195","doi-asserted-by":"crossref","first-page":"11865","DOI":"10.18632\/aging.102465","article-title":"MicroRNA 27b promotes cardiac fibrosis by targeting the FBW7\/Snail pathway","volume":"11","author":"Fu","year":"2019","journal-title":"Aging"},{"issue":"9","key":"10.1016\/j.carpath.2024.107673_bib0196","doi-asserted-by":"crossref","first-page":"2150","DOI":"10.1111\/j.1582-4934.2012.01523.x","article-title":"Micro RNA-24 regulates cardiac fibrosis after myocardial infarction","volume":"16","author":"Wang","year":"2012","journal-title":"J Cell Mol Med"},{"key":"10.1016\/j.carpath.2024.107673_bib0197","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2022.106124","article-title":"MicroRNA-24-3p alleviates cardiac fibrosis by suppressing cardiac fibroblasts mitophagy via downregulating PHB2","volume":"177","author":"Zhang","year":"2022","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.carpath.2024.107673_bib0198","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/j.omtn.2018.04.005","article-title":"miR-24 and miR-122 negatively regulate the transforming growth factor-\u03b2\/smad signaling pathway in skeletal muscle fibrosis","volume":"11","author":"Sun","year":"2018","journal-title":"Mol Ther Nucleic Acids"},{"issue":"1","key":"10.1016\/j.carpath.2024.107673_bib0199","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1161\/CIRCRESAHA.111.244442","article-title":"Inhibition of miR-15 protects against cardiac ischemic injury","volume":"110","author":"Hullinger","year":"2012","journal-title":"Circ Res"},{"issue":"1","key":"10.1016\/j.carpath.2024.107673_bib0200","doi-asserted-by":"crossref","first-page":"66","DOI":"10.21037\/atm-20-6073","article-title":"A narrative review of the roles of the miR-15\/107 family in heart disease: lessons and prospects for heart disease","volume":"9","author":"Zheng","year":"2021","journal-title":"Ann Transl Med"},{"issue":"1","key":"10.1016\/j.carpath.2024.107673_bib0201","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1093\/cvr\/cvu184","article-title":"The microRNA-15 family inhibits the TGF\u03b2-pathway in the heart","volume":"104","author":"Tijsen","year":"2014","journal-title":"Cardiovasc Res"},{"issue":"1","key":"10.1016\/j.carpath.2024.107673_bib0202","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12967-015-0672-0","article-title":"Circulating microRNAs as biomarkers for diffuse myocardial fibrosis in patients with hypertrophic cardiomyopathy","volume":"13","author":"Fang","year":"2015","journal-title":"J Transl Med"},{"issue":"7","key":"10.1016\/j.carpath.2024.107673_bib0203","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1161\/CIRCULATIONAHA.112.094524","article-title":"MicroRNA-101 inhibited postinfarct cardiac fibrosis and improved left ventricular compliance via the FBJ osteosarcoma oncogene\/transforming growth factor-beta1 pathway","volume":"126","author":"Pan","year":"2012","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.carpath.2024.107673_bib0204","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1159\/000369689","article-title":"MicroRNA-101a inhibits cardiac fibrosis induced by hypoxia via targeting TGF\u03b2RI on cardiac fibroblasts","volume":"35","author":"Zhao","year":"2015","journal-title":"Cell Physiol Biochem"},{"issue":"3","key":"10.1016\/j.carpath.2024.107673_bib0205","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1007\/s00894-023-05582-9","article-title":"MicroRNA\u2011378: an important player in cardiovascular diseases (review)","volume":"28","author":"Wang","year":"2023","journal-title":"Mol Med Rep"},{"issue":"9","key":"10.1016\/j.carpath.2024.107673_bib0206","doi-asserted-by":"crossref","first-page":"2565","DOI":"10.7150\/thno.22878","article-title":"MicroRNA-378 suppresses myocardial fibrosis through a paracrine mechanism at the early stage of cardiac hypertrophy following mechanical stress","volume":"8","author":"Yuan","year":"2018","journal-title":"Theranostics"},{"issue":"21","key":"10.1016\/j.carpath.2024.107673_bib0207","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.1161\/CIRCULATIONAHA.112.000882","article-title":"MiR-378 controls cardiac hypertrophy by combined repression of mitogen-activated protein kinase pathway factors","volume":"127","author":"Ganesan","year":"2013","journal-title":"Circulation"},{"key":"10.1016\/j.carpath.2024.107673_bib0208","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.yjmcc.2019.06.011","article-title":"LncRNA PCFL promotes cardiac fibrosis via miR-378\/GRB2 pathway following myocardial infarction","volume":"133","author":"Sun","year":"2019","journal-title":"J Mol Cell Cardiol"},{"issue":"1","key":"10.1016\/j.carpath.2024.107673_bib0209","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1161\/CIRCRESAHA.115.303970","article-title":"MicroRNA miR145 regulates TGFBR2 expression and matrix synthesis in vascular smooth muscle cells","volume":"116","author":"Zhao","year":"2015","journal-title":"Circ Res"},{"issue":"2","key":"10.1016\/j.carpath.2024.107673_bib0210","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1002\/jcb.29843","article-title":"miR-145 attenuates cardiac fibrosis through the AKT\/GSK-3\u03b2\/\u03b2-catenin signaling pathway by directly targeting SOX9 in fibroblasts","volume":"122","author":"Cui","year":"2021","journal-title":"J Cell Biochem"},{"key":"10.1016\/j.carpath.2024.107673_bib0211","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.ijcard.2022.01.024","article-title":"CREB1 transcription-activated lncRNA PVT1 promotes cardiac fibrosis via miR-145\/HCN1 axis","volume":"353","author":"Tian","year":"2022","journal-title":"Int J Cardiol"},{"issue":"3","key":"10.1016\/j.carpath.2024.107673_bib0212","doi-asserted-by":"crossref","first-page":"2997","DOI":"10.1002\/jcp.27117","article-title":"Long noncoding RNA MALAT1 mediates cardiac fibrosis in experimental postinfarct myocardium mice model","volume":"234","author":"Huang","year":"2019","journal-title":"J Cell Physiol"},{"key":"10.1016\/j.carpath.2024.107673_bib0213","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2020.173374","article-title":"MicroRNA-122 aggravates angiotensin II-mediated apoptosis and autophagy imbalance in rat aortic adventitial fibroblasts via the modulation of SIRT6-elabela-ACE2 signaling","volume":"883","author":"Song","year":"2020","journal-title":"Eur J Pharmacol"},{"issue":"5","key":"10.1016\/j.carpath.2024.107673_bib0214","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1007\/s10741-020-09957-5","article-title":"The Elabela-APJ axis: a promising therapeutic target for heart failure","volume":"26","author":"Ma","year":"2021","journal-title":"Heart Fail Rev"},{"key":"10.1016\/j.carpath.2024.107673_bib0215","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2020.107511","article-title":"Targeting the NLRP3 inflammasome to treat cardiovascular fibrosis","volume":"209","author":"Pinar","year":"2020","journal-title":"Pharmacol Ther"},{"issue":"10","key":"10.1016\/j.carpath.2024.107673_bib0216","doi-asserted-by":"crossref","first-page":"2183","DOI":"10.1253\/circj.CJ-16-0568","article-title":"Circulating miR-122-5p\/miR-133b ratio is a specific early prognostic biomarker in acute myocardial infarction","volume":"80","author":"Cortez-Dias","year":"2016","journal-title":"Circ J"},{"key":"10.1016\/j.carpath.2024.107673_bib0217","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.lfs.2018.11.016","article-title":"A meta-analysis of dysregulated miRNAs in coronary heart disease","volume":"215","author":"Wang","year":"2018","journal-title":"Life Sci"},{"issue":"7","key":"10.1016\/j.carpath.2024.107673_bib0218","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1042\/CS20130538","article-title":"microRNA-122 down-regulation may play a role in severe myocardial fibrosis in human aortic stenosis through TGF-\u03b21 up-regulation","volume":"126","author":"Beaumont","year":"2014","journal-title":"Clin Sci (Lond)"},{"issue":"6","key":"10.1016\/j.carpath.2024.107673_bib0219","first-page":"1130","article-title":"Diabetic cardiomiopathy progression is triggered by miR122-5p and involves extracellular matrix: a 5-year prospective study","volume":"14","author":"Pofi","year":"2021","journal-title":"JACC: Cardiovasc Imaging"},{"issue":"4","key":"10.1016\/j.carpath.2024.107673_bib0220","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1007\/s00395-008-0715-2","article-title":"Reduced MMP-2 activity contributes to cardiac fibrosis in experimental diabetic cardiomyopathy","volume":"103","author":"Van Linthout","year":"2008","journal-title":"Basic Res Cardiol"},{"issue":"4","key":"10.1016\/j.carpath.2024.107673_bib0221","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1016\/j.bbrc.2019.09.035","article-title":"MicroRNA-122 promotes cardiomyocyte hypertrophy via targeting FoxO3","volume":"519","author":"Song","year":"2019","journal-title":"Biochem Biophys Res Commun"},{"issue":"4","key":"10.1016\/j.carpath.2024.107673_bib0222","doi-asserted-by":"crossref","first-page":"e64","DOI":"10.1161\/CIRCULATIONAHA.122.061834","volume":"147","author":"Halushka","year":"2023","journal-title":"Circulation"},{"key":"10.1016\/j.carpath.2024.107673_bib0223","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/j.omtn.2020.04.007","article-title":"A roadmap for fixing the heart: RNA regulatory networks in cardiac disease","volume":"20","author":"Tang","year":"2020","journal-title":"Mol Ther Nucleic Acids"},{"issue":"3","key":"10.1016\/j.carpath.2024.107673_bib0224","doi-asserted-by":"crossref","first-page":"2997","DOI":"10.1002\/jcp.27117","article-title":"Long noncoding RNA MALAT1 mediates cardiac fibrosis in experimental postinfarct myocardium mice model","volume":"234","author":"Huang","year":"2019","journal-title":"J Cell Physiol"},{"issue":"4","key":"10.1016\/j.carpath.2024.107673_bib0225","doi-asserted-by":"crossref","first-page":"874","DOI":"10.7150\/thno.23364","article-title":"LET's sponge: how the lncRNA PFL promotes cardiac fibrosis","volume":"8","author":"Leisegang","year":"2018","journal-title":"Theranostics"},{"issue":"4","key":"10.1016\/j.carpath.2024.107673_bib0226","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.7150\/thno.20846","article-title":"LncRNA PFL contributes to cardiac fibrosis by acting as a competing endogenous RNA of let-7d","volume":"8","author":"Liang","year":"2018","journal-title":"Theranostics"},{"issue":"395","key":"10.1016\/j.carpath.2024.107673_bib0227","doi-asserted-by":"crossref","first-page":"eaai9118","DOI":"10.1126\/scitranslmed.aai9118","article-title":"The long noncoding RNA wisper controls cardiac fibrosis and remodeling","volume":"9","author":"Micheletti","year":"2017","journal-title":"Sci Transl Med"},{"issue":"1","key":"10.1016\/j.carpath.2024.107673_bib0228","doi-asserted-by":"crossref","first-page":"7743","DOI":"10.1038\/ncomms8743","article-title":"MEG3 long noncoding RNA regulates the TGF-\u03b2 pathway genes through formation of RNA\u2013DNA triplex structures","volume":"6","author":"Mondal","year":"2015","journal-title":"Nat Commun"},{"issue":"5","key":"10.1016\/j.carpath.2024.107673_bib0229","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1161\/CIRCRESAHA.117.310624","article-title":"Inhibition of the cardiac fibroblast-enriched lncRNA Meg3 prevents cardiac fibrosis and diastolic dysfunction","volume":"121","author":"Piccoli","year":"2017","journal-title":"Circ Res"},{"key":"10.1016\/j.carpath.2024.107673_bib0230","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.tox.2017.05.007","article-title":"LncRNA GAS5 controls cardiac fibroblast activation and fibrosis by targeting miR-21 via PTEN\/MMP-2 signaling pathway","volume":"386","author":"Tao","year":"2017","journal-title":"Toxicology"},{"issue":"10","key":"10.1016\/j.carpath.2024.107673_bib0231","first-page":"4414","article-title":"Overexpression of lncRNA GAS5 attenuates cardiac fibrosis through regulating PTEN\/MMP-2 signal pathway in mice","volume":"23","author":"Liu","year":"2019","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"10.1016\/j.carpath.2024.107673_bib0232","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.omtn.2020.11.013","article-title":"Long noncoding RNA Cfast regulates cardiac fibrosis","volume":"23","author":"Zhang","year":"2021","journal-title":"Mol Ther Nucleic Acids"}],"container-title":["Cardiovascular Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1054880724000693?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1054880724000693?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,9,12]],"date-time":"2024-09-12T06:17:41Z","timestamp":1726121861000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1054880724000693"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11]]},"references-count":232,"alternative-id":["S1054880724000693"],"URL":"https:\/\/doi.org\/10.1016\/j.carpath.2024.107673","relation":{},"ISSN":["1054-8807"],"issn-type":[{"value":"1054-8807","type":"print"}],"subject":[],"published":{"date-parts":[[2024,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Current concepts in the epigenetic regulation of cardiac fibrosis","name":"articletitle","label":"Article Title"},{"value":"Cardiovascular Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.carpath.2024.107673","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"107673"}}